Side-by-side comparison of price performance, valuation, growth, profitability, analyst targets and technical trend.
Each line starts at 100 so growth is directly comparable
| Metric | VCYT | GH |
|---|---|---|
| Price | $47.67 | $187.22 |
| Change today | ▲ 4.06% | ▲ 5.30% |
| Market cap | $3.83B | $25.12B |
| Return, 3 months | -15.1% | +14.9% |
| Return, year to date | +13.2% | +83.3% |
| Return, 1 year | +32.3% | +195.4% |
| P/E (TTM) | 34.1 | -53.3 |
| P/B | 2.8 | -112.7 |
| P/E percentile vs own 5y | 71st | 0th |
| Dividend yield | – | – |
| Revenue growth (YoY, latest qtr) | +15.5% | +44.3% |
| Net profit growth (YoY) | +2,701.0% | -20.3% |
| Gross margin | 72.2% | 65.0% |
| Operating margin | 15.3% | -39.7% |
| Net margin | 17.0% | -38.3% |
| Return on equity | – | – |
| Analyst target vs. price | +25.4% | +7.6% |
| Analyst buy share | 82% | 100% |
| RSI (14) | 59 | 67 |
| 30-day volatility | 60.6% | 42.7% |
| Max drawdown, 1 year | -39.2% | -33.0% |
| Trend read | Strong uptrend | Strong uptrend |
| Analyst consensus | Buy | Buy |
Green cells mark the best value in each row where "better" is clear-cut (lower P/E, higher margin). That is a reading of the numbers, not a recommendation. Financials are in each company's reporting currency.
